ETH Zürich - Numerische Materialmodellierung
8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)
ETH Zürich - Numerische Materialmodellierung
Technoparkstrasse 1
8005 Zürich
163 Ergebnisse für "therapeutics" unter ETH Zürich - Numerische Materialmodellierung
Novel therapeutics – Synthetic Biology Group | ETH Zurich
... Novel therapeutics Novel therapeutics One of the most exciting applications of information ... Novel therapeutics – Synthetic Biology Group | ETH Zurich ... Novel therapeutics – Synthetic Biology Group | ETH Zurich Press Enter to activate screen reader ... Novel therapeutics – Synthetic Biology Group | ETH Zurich ...
Novel therapeutics – Synthetic Biology Group | ETH Zurich
... Novel therapeutics Novel therapeutics One of the most exciting applications of information ... Novel therapeutics – Synthetic Biology Group | ETH Zurich ... Novel therapeutics – Synthetic Biology Group | ETH Zurich Press Enter to activate screen reader ... Novel therapeutics – Synthetic Biology Group | ETH Zurich ...
ETH Zürich - Feasibility Lab
Technoparkstrasse 1
8005 Zürich
281 Ergebnisse für "therapeutics" unter ETH Zürich - Feasibility Lab
Tandem Therapeutics One Pager Mamta Chabria
... Tandem Therapeutics One Pager Mamta Chabria Unlocking the matrix barrier in fibrotic disease Proof ... class of therapeutics that have the potential to revolutionize immunooncology treatments for fibrotic ... Tandem Therapeutics One Pager Mamta Chabria ... Tandem Therapeutics One Pager Mamta Chabria Unlocking the matrix barrier in fibrotic disease Proof ... Tandem Therapeutics One Pager Mamta Chabria ...
BSSE spinoff Engimmune raises seed financing to develop novel T-cel...
... BSSE spinoff Engimmune raises seed financing to develop novel T-cell receptor therapeutics BSSE ... spinoff Engimmune raises seed financing to develop novel T-cell receptor therapeutics Exciting news from ... BSSE spinoff Engimmune raises seed financing to develop novel T-cell receptor therapeutics ... BSSE spinoff Engimmune raises seed financing to develop novel T-cell receptor therapeutics ... BSSE spinoff Engimmune raises seed financing to develop novel T-cell receptor therapeutics ...
CSEM Zurich SA
8005 Zürich, Technoparkstrasse 1 / Zeppelin 5011
+41 44 497 14 11
zurich@csem.ch
The Centre Suisse d'Electronique et de Microtechnique (CSEM) is a national innovation accelerator—a catalyst for the transfer of technologies and know-how from fundamental research to industry.
CSEM Zurich SA
Technoparkstrasse 1
8005 Zürich
4 Ergebnisse für "therapeutics" unter CSEM Zurich SA
Personalized drug discovery at lightspeed
... Therapeutics and CSEM are collaborating to develop and manufacture single-cell microfluidics that will enable ... immunotherapies for each patient in cancers and autoimmune diseases HiFiBiO Therapeutics, a multinational ... ) HiFiBiO Therapeutics and CSEM are collaborating to develop and manufacture single-cell microfluidics that ... patient. Curative immunotherapies for each patient in cancers and autoimmune diseases HiFiBiO Therapeutics ...
Personalized drug discovery at lightspeed
... Therapeutics and CSEM are collaborating to develop and manufacture single-cell microfluidics that will enable ... immunotherapies for each patient in cancers and autoimmune diseases HiFiBiO Therapeutics, a multinational ... (Cet article n'est disponible qu'en anglais) HiFiBiO Therapeutics and CSEM are collaborating to develop ... HiFiBiO Therapeutics, a multinational biotherapeutics company, that mobilizes the human immune system to ...
Versantis AG
8005 Zürich, Technoparkstrasse 1 / Darwin 3018
+41 44 500 88 91
info@versantis.ch
Versantis is a pharmaceutical company revolutionizing the care of liver disease patients with a new generation of medicines and diagnostics. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide.
Versantis AG
Technoparkstrasse 1
8005 Zürich
1 Ergebnisse für "therapeutics" unter Versantis AG
Versantis
... Versantis develops a new generation of liver disease therapeutics and diagnostics. We are committed ... develops a new generation of liver disease therapeutics and diagnostics. We are committed to the ...
COMSOL MULTIPHYSICS GmbH
8005 Zürich, Technoparkstrasse 1 / Darwin 3002
+41 44 515 78 00
info-ch@comsol.com
COMSOL is a global provider of simulation software for product design and research. Its COMSOL Multiphysics® product includes functionality for creating physics-based models and simulation applications. Add-on products connect seamlessly via the platform to bring specialized functionality for electromagnetics, structural mechanics, acoustics, fluid flow, heat transfer, and chemical engineering.
COMSOL MULTIPHYSICS GmbH
Technoparkstrasse 1
8005 Zürich
1 Ergebnisse für "therapeutics" unter COMSOL MULTIPHYSICS GmbH
Simulation of Chemotractant Gradients in Microfluidic Channels to S...
... important process in vivo and an interesting target for cancer therapeutics. Microfluidics offer very ... cancer therapeutics. Microfluidics offer very powerful tools to study such migration processes in detail ...
The Real Economy Effect GmbH
http://bootstrap-europe.com/team
8005 Zürich, Technoparkstrasse 1 / Transfer Süd 3001
+41 79 310 69 78
info@bootstrapeurope.com
Growth debt for scale-up businesses. Take your next step to growth with Bootstrap Europe. We provide progressive, ambitious entrepreneurs and shareholders with non-dilutive funding to help them succeed.
The Real Economy Effect GmbH
Technoparkstrasse 1
8005 Zürich
2 Ergebnisse für "therapeutics" unter The Real Economy Effect GmbH
Home - Bootstrap Europe
... behind our scale-up’s journey with us over at our blog. MiNA Therapeutics case study “Bootstrap was ... scale-up’s journey with us over at our blog. MiNA Therapeutics case study “ Bootstrap was critical to us ...
Team — Bootstrap Europe
... Development at Phairson Medical Ltd. In 2000, he co-founded Kuros Therapeutics AG, which was successfully sold ... at Phairson Medical Ltd. In 2000, he co-founded Kuros Therapeutics AG, which was successfully sold in ...
Resmonics AG
8005 Zürich, Technoparkstrasse 1 / Transfer Süd 1005
+41 76 403 34 66
peter@resmonics.ai
Die Resmonics AG, ein Spin-Off der ETH Zürich und Universität St. Gallen, entwickelt ein KI-basiertes Sensorsystem für Spitäler, das in Echtzeit Gesundheitsrisiken für Mitarbeiter erkennt und mittels frühzeitiger Warnungen Krankheitsfälle verhindert.
Resmonics AG
Technoparkstrasse 1
8005 Zürich
1 Ergebnisse für "therapeutics" unter Resmonics AG
AI in hospitals - article by Resmonics co-founder in "Manager Magazin"
... , digital therapeutics and wearables can improve healthcare, but also point out the challenges, especially ... discuss how telemonitoring, digital therapeutics and wearables can improve healthcare, but also point out ...
cellvie AG
Technoparkstrasse 1
8005 Zürich
1 Ergebnisse für "therapeutics" unter cellvie AG
CELLVIE: Reviving cell metabolism via mitochondrial transplant
... transplantation of the organelle, Minovia Therapeutics Ltd. is enriching CD34+ stem cells with blood-derived ... Therapeutics Ltd. is enriching CD34+ stem cells with blood-derived mitochondria and using the cells to treat ...
ETH Zürich - Institut für Werkzeugmaschinen IWF
8005 Zürich, Technoparkstrasse 1 / Werkhalle A 0003
+41 44 633 80 83
martin.stoeckli@inspire.ch
Mechanische WerkstattBenötigen Sie professionelle Hilfe für die fertigungsgerechte Konstruktion oder im Bereich der Fertigungstechnik? Haben Sie ein messtechnisches Problem? Oder haben Sie eine gute Idee, können diese aber nicht selber realisieren?Die Werkstatt des IWF bietet Studenten, Assistenten und Jungfirmen Unterstützung bei der Umsetzung ihrer Ideen. Hierfür stehen erfahrene Mechaniker und Techniker beratend und tatkräftig zur Verfügung, welche es verstehen, Ihre Ideen zum Erfolg zu führen.
ETH Zürich - Institut für Werkzeugmaschinen IWF
Technoparkstrasse 1
8005 Zürich
3 Ergebnisse für "therapeutics" unter ETH Zürich - Institut für Werkzeugmaschinen IWF
Acoustic micro- and nanorobots for medicine – Department of Mechani...
... unravel many of the puzzles associated with transforming micro-robots into therapeutics for medicine. You ... therapeutics for medicine. You started this project in 2015 when you joined the Multi-Scale Robotics Lab. Why ...
Industrial Advisory Board – Department of Mechanical and Process En...
... 2000 he co-founded Kuros Therapeutics in Zurich. In 2002 Sandro Matter became head of the Biologics and ... Therapeutics in Zurich. In 2002 Sandro Matter became head of the Biologics and Research Division at the ...
Sequana Medical NV, Ghent, Zweigniederlassung Zürich
https://www.sequanamedical.com/
8005 Zürich, Technoparkstrasse 1 / Darwin 2009
+41 44 403 55 00
info@sequanamedical.com
Sequana Medical is a commercial stage medical device company and an innovator in the management of liver disease. The first product, alfapump®, is a fully implantable, programmable, transcutaneously-charged, battery-powered pump for the management of refractory ascites (chronic fluid build-up in the abdomen). Through the experience from the design, development, manufacture and commercialisation of the alfapump, together with the extensive intellectual property portfolio, Sequana Medical is developing an enabling platform for the management of heart failure and other fluid-imbalance disorders
Sequana Medical NV, Ghent, Zweigniederlassung Zürich
Technoparkstrasse 1
8005 Zürich
2 Ergebnisse für "therapeutics" unter Sequana Medical NV, Ghent, Zweigniederlassung Zürich
Clinical research - Sequana Medical
... (NCT01532427). Stirnimann et al., Alimentary Pharmacology & Therapeutics, 2017 (data on the first 56 patients ... ) Editorial by Macdonald and Jalan, Alimentary Pharmacology & Therapeutics, 2017 RCT Prospective, multi-centre ...
Niet-gereglementeerd Archives - Page 7 of 7 - Sequana Medical
... & Therapeutics (AP&T). Oktober 4, 2017 vittorio Persberichten Sequana Medical AG (Sequana Medical), a commercial ...
